Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

63.10
Delayed Data
As of Feb 05
 -1.12 / -1.74%
Today’s Change
35.78
Today|||52-Week Range
121.95
-17.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues61.8M58.3M59.1M62.2M
 
 
 
 
 
Cost of Goods Sold16.3M14.8M16.1M13.0M
 
 
 
 
 
Depreciation And Amortization2.7M2.7M2.8M2.9M
 
 
 
 
 
 
Operating ExpensesGross Income42.8M40.7M40.2M46.3M
 
 
 
 
 
General Expenses34.9M37.4M38.4M41.2M
 
 
 
 
 
Research And Development3.9M6.0M3.6M5.9M
 
 
 
 
 
Total Operating Expenses53.9M55.0M57.3M57.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income7.9M3.3M1.8M5.1M
 
 
 
 
 
Extraordinary Charge0.000.00-51.0K0.00
 
 
Interest Expense On Debt2.1M2.3M2.1M2.1M
 
 
 
 
 
Other Expenses-41.0K-117.0K43.0K-8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.0M1.3M47.0K3.4M
 
 
 
 
 
Income Taxes-173.0K-52.0K-39.0K-281.0K
 
 
 
 
 
Net Income5.8M1.3M8.0K3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.1M36.2M36.5M36.7M
 
 
 
 
 
Shares To Calculate EPS Diluted41.6M41.8M41.4M41.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14$0.03$0.00$0.08
 
 
 
 
EPS Diluted$0.14$0.03$0.00$0.08